MENU

CTOR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Citius Oncology (CTOR) Ownership - Who owns Citius Oncology?

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Pharmaceuticals

Capitalization

66.37M

P/E Ratio

N/A

Total Cash

2.63M

Projected Growth

N/A

Total Debt

3.8M

Revenue

5.61M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

0.03

Total Debt/Equity

N/A

Revenue/Share

0.07 USD as % of share price

View a ticker or compare two or three

VS

VS

CTOR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CTOR

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsGeneric

Profile

Details